Jack Kaye - Net Worth and Insider Trading
Jack Kaye Net Worth
The estimated net worth of Jack Kaye is at least $630,004 dollars as of 2024-04-26. Jack Kaye is the Director of Keryx Biopharmaceuticals Inc and owns about 141,400 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $475,104. Jack Kaye is also the Director of uniQure NV and owns about 34,119 shares of uniQure NV (QURE) stock worth over $154,900. Details can be seen in Jack Kaye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jack Kaye has not made any transactions after 2023-06-16 and currently still holds the listed stock(s).
Transaction Summary of Jack Kaye
Jack Kaye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jack Kaye owns 3 companies in total, including uniQure NV (QURE) , Dyadic International Inc (DYAI) , and Keryx Biopharmaceuticals Inc (KERX) .
Click here to see the complete history of Jack Kaye’s form 4 insider trades.
Insider Ownership Summary of Jack Kaye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QURE | uniQure NV | 2023-06-16 | director |
| DYAI | Dyadic International Inc | 2019-06-25 | director |
| KERX | Keryx Biopharmaceuticals Inc | 2015-06-17 | director |
Jack Kaye Latest Holdings Summary
Jack Kaye currently owns a total of 2 stocks. Among these stocks, Jack Kaye owns 141,400 shares of Keryx Biopharmaceuticals Inc (KERX) as of December 6, 2010, with a value of $475,104 and a weighting of 75.41%. Jack Kaye also owns 34,119 shares of uniQure NV (QURE) as of June 16, 2023, with a value of $154,900 and a weighting of 24.59%.
Latest Holdings of Jack Kaye
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KERX | Keryx Biopharmaceuticals Inc | 2010-12-06 | 141,400 | 3.36 | 475,104 |
| QURE | uniQure NV | 2023-06-16 | 34,119 | 4.54 | 154,900 |
Holding Weightings of Jack Kaye
Jack Kaye Form 4 Trading Tracker
According to the SEC Form 4 filings, Jack Kaye has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 20,000 shares on December 6, 2010, which brought Jack Kaye around $100,000.
According to the SEC Form 4 filings, Jack Kaye has made a total of 4 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in uniQure NV is the sale of 2,280 shares on June 16, 2023, which brought Jack Kaye around $43,160.
Insider Trading History of Jack Kaye
- 1
Jack Kaye Trading Performance
GuruFocus tracks the stock performance after each of Jack Kaye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack Kaye is 107.95%. GuruFocus also compares Jack Kaye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack Kaye within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jack Kaye's insider trading performs compared to the benchmark.
Performance of Jack Kaye
Average Return
495.13%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 55.13 | 107.95 | 215.85 | 495.13 | 92.12 | 15.93 |
| Relative Return to S&P 500(%) | 54.16 | 100.26 | 206.96 | 490.02 | 92.02 | 13.9 |
Jack Kaye Ownership Network
Ownership Network List of Jack Kaye
Ownership Network Relation of Jack Kaye
Jack Kaye Owned Company Details
What does uniQure NV do?
Who are the key executives at uniQure NV?
Jack Kaye is the director of uniQure NV. Other key executives at uniQure NV include director & CEO & Managing Director Matthew C Kapusta , Chief Financial Officer Christian Klemt , and Chief Operating Officer Pierre Caloz .
uniQure NV (QURE) Insider Trades Summary
Over the past 18 months, Jack Kaye made no insider transaction in uniQure NV (QURE). Other recent insider transactions involving uniQure NV (QURE) include a net sale of 31,423 shares made by Pierre Caloz , a net sale of 21,275 shares made by Paula Soteropoulos , and a net sale of 21,087 shares made by Christian Klemt .
In summary, during the past 3 months, insiders sold 53,265 shares of uniQure NV (QURE) in total and bought 0 shares, with a net sale of 53,265 shares. During the past 18 months, 140,026 shares of uniQure NV (QURE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 140,026 shares.
uniQure NV (QURE)'s detailed insider trading history can be found in Insider Trading Tracker table.
uniQure NV Insider Transactions
Jack Kaye Mailing Address
Above is the net worth, insider trading, and ownership report for Jack Kaye. You might contact Jack Kaye via mailing address: C/o Keryx Biopharmaceuticals, 750 Lexington Avenue, New York X1 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
